Which of the following is NOT associated with massive transfusion: March 2013 (a, f)
**Core Concept**
Massive transfusion refers to the administration of large volumes of blood or blood products, typically exceeding 10 units of packed red blood cells, within a short period. This scenario often occurs in trauma patients, surgical cases, or obstetric emergencies, requiring careful management to prevent complications such as dilutional coagulopathy, hypothermia, and citrate toxicity.
**Why the Correct Answer is Right**
Massive transfusion protocols often involve the use of specific ratios of blood products, including red blood cells, fresh frozen plasma (FFP), and platelets. The goal is to maintain adequate coagulation factors and prevent dilutional coagulopathy. The use of tranexamic acid (TXA) has become a standard component of massive transfusion protocols, as it helps to inhibit fibrinolysis and reduce bleeding.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because tranexamic acid is actually associated with massive transfusion protocols to prevent bleeding and coagulopathy.
**Option B:** This option is incorrect because the use of a specific ratio of blood products, including red blood cells, FFP, and platelets, is a fundamental aspect of massive transfusion protocols.
**Option C:** This option is incorrect because the administration of vasopressors, such as norepinephrine, may be necessary in the setting of massive transfusion to maintain blood pressure and prevent shock.
**Option D:** This option is incorrect because the use of point-of-care coagulation testing, such as thromboelastography (TEG) or rotational thromboelastometry (ROTEM), is essential in the management of massive transfusion to guide blood product administration and prevent coagulopathy.
**Clinical Pearl / High-Yield Fact**
In the setting of massive transfusion, it's essential to remember that citrate toxicity can occur due to the high doses of citrate anticoagulant in stored blood products. This can lead to hypocalcemia, which can be managed by administering calcium gluconate or calcium chloride.
**Correct Answer: D. The use of point-of-care coagulation testing, such as thromboelastography (TEG) or rotational thromboelastometry (ROTEM), is NOT associated with massive transfusion.**